Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
High-Resolution HLA Typing for Sensitized Patients: Advances in Medicine and Science Require Us to Challenge Existing Paradigms.
Development of a PET radioligand for potassium channels to image CNS demyelination.
Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings. AJR Am J Roentgenol. 2018 Mar; 210(3):503-513.
View in:
PubMed
subject areas
Diagnosis, Differential
Early Detection of Cancer
Humans
Incidental Findings
Lung Diseases, Interstitial
Lung Neoplasms
Mass Screening
Pulmonary Disease, Chronic Obstructive
Pulmonary Emphysema
Radiation Dosage
Radiography, Thoracic
Smoking
Tomography, X-Ray Computed
authors with profiles
Jonathan Chung